| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |